Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients

Journal of Hepatology

Volumn 37, Issue 6, 2002, Pages 753-761

  Fabio, Giovanna ^a   Zarantonello, Marina ^a   Mocellin, Cristina ^a   Bonara, Paola ^b   Corengia, Chiara ^a   Fargion, Silvia ^a   Fiorelli, Gemino ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Hereditary hemochromatosis; Intracellular cytokines; NK cells; T cytotoxic cells; T cytotoxic 2 cells

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFERRIN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENETICS; HOMOZYGOTE; IMMUNOLOGY; INTRACELLULAR FLUID; INTRACELLULAR MEMBRANE; LYMPHOCYTE; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMANS; INTRACELLULAR FLUID; INTRACELLULAR MEMBRANES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTE SUBSETS; TRANSFERRIN;

EID: 0036893626     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00276-3     Document Type: Article

References (37)

1. Andrews NC, Levy JE. Iron is hot: An update on the pathophysiology of hemochromatosis. Blood 1998;92:1845-1851.
2. Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001;33:647-651.
3. Feder JN, Gnirke A, Thomas W, Thomas W, Tsuchihashi Z, Ruddy DA, et al. A novel MHC class I-like gene is mutated in patient with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
4. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272:14025-14028.
5. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997;94:12384-12389.
6. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, et al. Association of the transferrin receptor in human placenta with HFE the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997;94:13198-13202.
7. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 1981;78:3039-3043.
8. Bayer AL, Baliga P, Woodward JE. Transferrin receptor in T cell activation and transplantation. J Leukoc Biol 1998;64:19-24.
9. Golding S, Young SP. Iron requirements of human lymphocytes: Relative contributions of intra- and extra-cellular iron. Scand J Immunol 1995;41:229-236.
10. Salmeron A, Borroto A, Fresno M, Crumpton MJ, Ley SC, Alarcon B, et al. Transferrin receptor induces tyrosine phosphorylation in T cells and is physically associated with the TCR ζ-chain. J Immunol 1995;154:1675-1683.
11. Chitambar CR, Wereley JP. Iron transport in a lymphoid cell line with hemochromatosis C282Y mutation. Blood 2001;97:2734-2740.
12. + lymphocytes and iron overload. Eur J Haematol 1994;52:283-290.
13. Arosa FA, da Silva AJ, Godinho IM, ter Steege JC, Porto G, Rudd CE, et al. Decreased CD8-p561ck activity in peripheral blood T-lymphocytes from patients with hereditary haemochromatosis. Scand J Immunol 1994;39:426-432.
14. Cardoso C, Porto G, La Cerda R, Resende D, Rodrigues P, Bravo FT-cell, et al. receptor repertoire in hereditary hemochromatosis: A study of 32 hemochromatosis patients and 274 healthy subjects. Hum Immunol 2001;62:488-499.
15. - T-cell. Clin Exp Immunol 1997;107:548-554.
16. de Sousa M, Porto G, Arosa FA, Cardoso C, Cabeda JM, LaCerda R, et al. T-lymphocyte expression and function in hemochromatosis. In: Barton JC, Edwards CQ, et al., editors. Hemochromatosis: Genetics, Pathophysiology, Diagnosis, and Treatment, Cambridge: Cambridge University Press, 2000. pp. 396-407.
17. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relative of patients with hemochromatosis. J Pathol Bateriol 1962;84:53-64.
18. Prussin C. Cytokine flow cytometry: Understanding cytokine biology single cell level. J Clin Immunol 1997;17:195-204.
19. Anderson SJ, Coleclough C. Regulation of CD4 and CD8 expression on mouse T cells. J Immunol 1993;151:5123-5134.
20. Porto G, Vicente C, Teixeira MA, Martins O, Cabeda JM, Lacerda R, et al. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology 1997;25:397-402.
21. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Gen 2000;66:1246-1258.
22. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 co-stimulatory molecules activated differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1997;80:707-718.
23. De Sousa M. Immune cell function in iron overload. Clin Exp Immunol 1989;75:1-6.
24. Lopez-Botet M, Bellon T. Natural killer cells activation and inhibition by receptor for MHC class-I. Curr Opin Immunol 1999;11:301-307.
25. Bahram S, Gilfillan S, Kuhn LC, Moret R, Schulze JB, Lebeau A, et al. Experimental hemochromatosis due to MHC class I HFE deficiency: Immune status and iron metabolism. Proc Natl Acad Sci USA 1999;96:13312-13317.
26. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunophatol 1996;80:225-232.
27. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
28. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-146.
29. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998;19:157-162.
30. Seder R, Le Gros G. The functional role of CD8 T helper type 2 cells. J Exp Med 1995;181:5-7.
31. Villacres MC, Bergmann CC. Enhanced cytotoxic T cell activity in IL-4-deficient mice. J Immunol 1999;162:2663-2670.
32. +CD8 dull positive cells produce IL-4 in AIDS patients. Br J Haematol 1998;101:74-77.
33. Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, et al. Human non-small cell lung cancer cells expressa type 2 cytokine pattern. Cancer Res 1995;55:3847-3853.
34. Wojciechowska-Lacka A, Matecka-Nowak M, Adamiak E, Lacki JK, Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma 1996;43:155-158.
35. Ito N, Nakamura H, Tanaka Y, Ohgi S. Lung carcinoma: Analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer 1999;85:2359-2367.
36. Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998;28:84-90.
37. + cells in the liver lobuli. Eur J Clin Invest 2001;31:45-53.